Somatostatin Analogs Market by Type (Octreotide, Lanreotide and Pasireotide), Application (Acromegaly, Neuroendocrine Tumors (NETs) and Others), End User (Hospital and Pharmaceutical Companies), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2023 to 2032

  • Publish Date: Jul, 2023
  • Report ID: 420539
  • Category: Healthcare
  • Pages: 236
$4700

The somatostatin analogs market is expected to grow from USD 6,780 million in 2022 to USD 15,357.75 million by 2032, at a CAGR of 8.52% during the forecast period 2023-2032.

Somatostatin analogs are the synthetic version of somatostatin. Somatostatin plays a regulatory role in various physiological processes, including inhibiting the secretion of several other hormones. Somatostatin analogs are primarily used to treat hormonal disorders. Somatostatin analogs are administered by injection. The common side effects of somatostatin analogs may include injection site reactions, gastrointestinal disturbances such as diarrhoea and abnormalities in liver function.

The increasing prevalence of hormonal disorders is one of the major factors driving the Somatostatin Analogs market. Increasing diagnosis has led to early detection, which increased the need for Somatostatin Analogs. In addition, growing awareness among healthcare professionals and patients also increases the demand for Somatostatin Analogs market. However, the high cost of treatment will hamper the market's growth. Additionally, the growing healthcare infrastructure will boost the growth of the Somatostatin Analogs market during the forecast period.

This study comprehensively analyses type, application, end user and region. The type segment includes octreotide, lanreotide and pasireotide. The octreotide segment registered the largest market share in 2022. The octreotide is utilized in various therapeutic applications. The application segment comprises acromegaly, neuroendocrine tumors (NETs) and others. The acromegaly segment held the largest market share in 2022. The presence of several treatments for acromegaly and awareness about acromegaly are the main factors which contribute to the growth of the segment. The end user segment is classified into hospital and pharmaceutical companies. The hospital segment generated the highest market revenue in 2022. The rise in the number of diagnosis and the increasing number of hospital admissions are the factors driving the segment's growth.

The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The North American region held the highest market revenue in 2022. It is mainly due to rising cases of neuroendocrine tumors and acromegaly. Also, rising awareness among the individual will boost the region's market growth. The presence of key players in the region will also boost the market’s growth. Asia Pacific region is anticipated to grow fastest over the forecast period. Growing population, technological advancement, and increasing healthcare infrastructure will likely drive the region's growth.

Some of the notable players in the market are Amryt Pharma plc, Camurus AB, Crinetics Pharmaceuticals, Ipsen Pharma, Novartis AG, Peptron Inc, Recordati Rare Diseases, Sun Pharmaceutical Industries Ltd and Teva Pharmaceuticals Inc among others.

  • Global Somatostatin Analogs Market Analysis and Forecast, Type
    • Octreotide
    • Lanreotide
    • Pasireotide
  • Global Somatostatin Analogs Market Analysis and Forecast, Application
    • Acromegaly
    • Neuroendocrine Tumors (NETs)
    • Others
  • Global Somatostatin Analogs Market Analysis and Forecast, End User
    • Hospital
    • Pharmaceutical Companies
  • Global Somatostatin Analogs Market Analysis and Forecast, Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • Sweden
      • Netherland
      • U.K.
      • Italy
      • Spain
      • Turkey
      • Switzerland
      • Belgium
      • Rest Of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
      • Singapore
      • Malaysia
      • Thailand
      • Indonesia
      • Philippines
      • Rest Of APAC
    • South America
      • Brazil
      • Argentina
      • Peru
      • Colombia
      • Rest Of South America
    • Middle East And Africa
      •  UAE
      •  Saudi Arabia
      •  Egypt
      •  Nigeria
      •  South Africa
      • Rest Of MEA

Report Description:

  • The base year for the study has been considered 2022, historic year 2019 to 2021, the forecast period considered is from 2023 to 2032.
  • The study delivers a comprehensive analysis of global market for all segments and region.
  • The report offers in-depth analysis of driving factors, opportunities and restraints for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2023 to 2032.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the market. This report incorporates the industry analysis which is focused on providing an extensive view of the market.
  • The study also includes attractiveness analysis of all segments and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunist for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Type
          4.3.2. Market Attractiveness Analysis by Application
          4.3.3. Market Attractiveness Analysis by End User
          4.3.4. Market Attractiveness Analysis by Region
    4.4. Industry Trends
5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing Prevalence of Hormonal Disorders
          5.2.2. Increasing Awareness and Diagnosis
    5.3. Restraints
          5.3.1. High Cost of Treatment
    5.4. Opportunities
          5.4.1. Growing healthcare infrastructure
    5.5. Challenges
          5.5.1. Regulatory Hurdles
6. Global Somatostatin Analogs Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Octreotide
    6.3. Lanreotide
    6.4. Pasireotide
7. Global Somatostatin Analogs Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Acromegaly
    7.3. Neuroendocrine Tumors (NETs)
    7.4. Others
8. Global Somatostatin Analogs Market Analysis and Forecast, By End User
    8.1. Segment Overview
    8.2. Hospital
    8.3. Pharmaceutical Companies
9. Global Somatostatin Analogs Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa
10. Global Somatostatin Analogs Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Somatostatin Analogs Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions
11. Company Profiles
    11.1. Amryt Pharma plc
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Camurus AB
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Crinetics Pharmaceuticals
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Ipsen Pharma
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Novartis AG
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Peptron Inc
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Peptron Inc
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Sun Pharmaceutical Industries Ltd
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Teva Pharmaceuticals Inc
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis

List of Table

1. Global Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

2. Global Octreotide, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

3. Global Octreotide, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

4. Global Pasireotide, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

5. Global Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

6. Global Acromegaly, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

7. Global Neuroendocrine Tumors (NETs), Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

8. Global Others, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

9. Global Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

10. Global Hospital, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

11. Global Pharmaceutical Companies, Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

12. Global Somatostatin Analogs Market, By Region, 2019-2032 (USD Million)

13. North America Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

14. North America Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

15. North America Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

16. U.S. Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

17. U.S. Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

18. U.S. Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

19. Canada Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

20. Canada Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

21. Canada Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

22. Mexico Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

23. Mexico Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

24. Mexico Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

25. Europe Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

26. Europe Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

27. Europe Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

28. Germany Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

29. Germany Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

30. Germany Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

31. France Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

32. France Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

33. France Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

34. U.K. Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

35. U.K. Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

36. U.K. Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

37. Italy Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

38. Italy Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

39. Italy Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

40. Spain Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

41. Spain Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

42. Spain Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

43. Asia Pacific Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

44. Asia Pacific Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

45. Asia Pacific Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

46. Japan Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

47. Japan Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

48. Japan Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

49. China Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

50. China Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

51. China Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

52. India Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

53. India Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

54. India Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

55. South America Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

56. South America Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

57. South America Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

58. Brazil Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

59. Brazil Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

60. Brazil Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

61. Middle East and Africa Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

62. Middle East and Africa Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

63. Middle East and Africa Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

64. UAE Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

65. UAE Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

66. UAE Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

67. South Africa Somatostatin Analogs Market, By Type, 2019-2032 (USD Million)

68. South Africa Somatostatin Analogs Market, By Application, 2019-2032 (USD Million)

69. South Africa Somatostatin Analogs Market, By End User, 2019-2032 (USD Million)

List of Figures 

1. Global Somatostatin Analogs Market Segmentation

2. Somatostatin Analogs Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Somatostatin Analogs Market Attractiveness Analysis by Type

9. Global Somatostatin Analogs Market Attractiveness Analysis by Application

10. Global Somatostatin Analogs Market Attractiveness Analysis by End User

11. Global Somatostatin Analogs Market Attractiveness Analysis by Region

12. Global Somatostatin Analogs Market: Dynamics

13. Global Somatostatin Analogs Market Share by Type (2023 & 2032)

14. Global Somatostatin Analogs Market Share by Application (2023 & 2032)

15. Global Somatostatin Analogs Market Share by End User (2023 & 2032)

16. Global Somatostatin Analogs Market Share by Regions (2023 & 2032)

17. Global Somatostatin Analogs Market Share by Company (2022)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.